Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt repayments
Ratios

Abvc Biopharma (ABVC) Long-Term Debt Repayments (2019 - 2024)

Historic Long-Term Debt Repayments for Abvc Biopharma (ABVC) over the last 7 years, with Q4 2024 value amounting to $147892.0.

  • Abvc Biopharma's Long-Term Debt Repayments changed N/A to $147892.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $327017.0 for FY2024, which is 8169.7% down from last year.
  • Latest data reveals that Abvc Biopharma reported Long-Term Debt Repayments of $147892.0 as of Q4 2024.
  • Abvc Biopharma's 5-year Long-Term Debt Repayments high stood at $1.0 million for Q1 2023, and its period low was $121.0 during Q3 2020.
  • Over the past 4 years, Abvc Biopharma's median Long-Term Debt Repayments value was $147892.0 (recorded in 2024), while the average stood at $245458.7.
  • Within the past 5 years, the most significant YoY rise in Abvc Biopharma's Long-Term Debt Repayments was 271628.32% (2020), while the steepest drop was 9904.65% (2020).
  • Quarter analysis of 4 years shows Abvc Biopharma's Long-Term Debt Repayments stood at $121.0 in 2020, then skyrocketed by 46871.9% to $56836.0 in 2021, then skyrocketed by 1659.45% to $1.0 million in 2023, then plummeted by 85.21% to $147892.0 in 2024.
  • Its Long-Term Debt Repayments stands at $147892.0 for Q4 2024, versus $1.0 million for Q1 2023 and $56836.0 for Q2 2021.